Mark-10 Introduces New Integrated Controls to Streamline Essential Force Measurement

Mark-10 introduces the Series F family of force testers for quality control and process monitoring in fabrication and assembly operations. The Series F family integrates IntelliMESUR software for machine control, force measurement, and data acquisition in a single clean graphical user interface. This brings another level of efficiency into recurrent testing, allowing users to define and store test sequences for both routine and unique tasks, store all measurements, and perform standard and specialized data analysis.

Mark-10 force and torque measuring instruments have long enjoyed a reputation for precision engineering and reliable operation in challenging environments. The new degree of operational simplicity in Series F force testers offers decreased test times for both routine and unique procedures to validate medical device manufacturing, measure packaging performance, confirm plastics formulation, check automotive module consistency, and verify aerospace component fabrication.

For example, medical syringe manufacturers must verify the syringe plunger force is within limits. The requirements vary with syringe geometry, so the test parameters must be adjusted for each different design. The Series F allows the full test procedure to be stored for each distinct geometry, and also allows the measured results to be correlated with syringe configuration, the plastic composition of the components, or any other elements that could influence syringe performance.

The same ease of operation and powerful data analysis can be applied to such applications as automobile seatbelt retraction force testing, package opening force verification for medication or consumer goods, and tension and compression measurements for plastic or metal test coupons for aerospace applications.

Mark Fridman, President of Mark-10, notes that the new Series F + IntelliMESUR allows more complex test sequences to be performed, without introducing more complexity for operators. “It’s more configurable, but is also easy to use. We anticipate our customers will see significant reductions in test time and cost, while having data analysis capabilities that bring added value to test operations.”

More information on the Series F + IntelliMESUR family is available at https://mark-10.com/seriesf/.

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.